1.28 USD
0 (0%)
1.2815 USD
+0 (+0.12%)
We assign a fundamental rating of 2 out of 10 to OPK. OPK was compared to 102 industry peers in the Health Care Providers & Services industry. OPK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. OPK is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- In the past year OPK has reported negative net income.
- OPK had a negative operating cash flow in the past year.
- OPK had negative earnings in 4 of the past 5 years.
- In multiple years OPK reported negative operating cash flow during the last 5 years.
1.2 Ratios
- OPK has a Return On Assets of -9.04%. This is in the lower half of the industry: OPK underperforms 69.61% of its industry peers.
- OPK has a worse Return On Equity (-13.82%) than 60.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.04% | ||
| ROE | -13.82% | ||
| ROIC | N/A |
ROA(3y)-8.99%
ROA(5y)-5.4%
ROE(3y)-12.84%
ROE(5y)-7.7%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Gross Margin, with a value of 35.29%, OPK is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
- OPK's Gross Margin has declined in the last couple of years.
- The Profit Margin and Operating Margin are not available for OPK so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 35.29% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.21%
GM growth 5Y-3.46%
2. Health
2.1 Basic Checks
- OPK does not have a ROIC to compare to the WACC, probably because it is not profitable.
- OPK has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, OPK has more shares outstanding
- Compared to 1 year ago, OPK has a worse debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of -0.49, we must say that OPK is in the distress zone and has some risk of bankruptcy.
- OPK has a worse Altman-Z score (-0.49) than 81.37% of its industry peers.
- A Debt/Equity ratio of 0.26 indicates that OPK is not too dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.26, OPK is in the better half of the industry, outperforming 69.61% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.49 |
ROIC/WACCN/A
WACC8.88%
2.3 Liquidity
- A Current Ratio of 3.70 indicates that OPK has no problem at all paying its short term obligations.
- OPK's Current ratio of 3.70 is amongst the best of the industry. OPK outperforms 89.22% of its industry peers.
- OPK has a Quick Ratio of 3.32. This indicates that OPK is financially healthy and has no problem in meeting its short term obligations.
- The Quick ratio of OPK (3.32) is better than 87.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.7 | ||
| Quick Ratio | 3.32 |
3. Growth
3.1 Past
- OPK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.35%, which is quite good.
- OPK shows a decrease in Revenue. In the last year, the revenue decreased by -9.75%.
- Measured over the past years, OPK shows a decrease in Revenue. The Revenue has been decreasing by -4.59% on average per year.
EPS 1Y (TTM)19.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.33%
Revenue 1Y (TTM)-9.75%
Revenue growth 3Y-26.21%
Revenue growth 5Y-4.59%
Sales Q2Q%-12.62%
3.2 Future
- The Earnings Per Share is expected to grow by 9.88% on average over the next years. This is quite good.
- Based on estimates for the next years, OPK will show a small growth in Revenue. The Revenue will grow by 0.51% on average per year.
EPS Next Y-57.34%
EPS Next 2Y-11.52%
EPS Next 3Y9.88%
EPS Next 5YN/A
Revenue Next Year-12.67%
Revenue Next 2Y-7.9%
Revenue Next 3Y-2.65%
Revenue Next 5Y0.51%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- OPK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year OPK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.52%
EPS Next 3Y9.88%
5. Dividend
5.1 Amount
- No dividends for OPK!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
1.28
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-29 2025-10-29/amc
Earnings (Next)02-25 2026-02-25/amc
Inst Owners26.11%
Inst Owner Change-0.05%
Ins Owners5.34%
Ins Owner Change0%
Market Cap982.66M
Revenue(TTM)642.07M
Net Income(TTM)-180.40M
Analysts80
Price Target3.74 (192.19%)
Short Float %8.27%
Short Ratio11.46
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)50.01%
Min EPS beat(2)-65.99%
Max EPS beat(2)166.01%
EPS beat(4)2
Avg EPS beat(4)41.56%
Min EPS beat(4)-65.99%
Max EPS beat(4)166.01%
EPS beat(8)4
Avg EPS beat(8)29.25%
EPS beat(12)7
Avg EPS beat(12)30.6%
EPS beat(16)7
Avg EPS beat(16)-123.82%
Revenue beat(2)0
Avg Revenue beat(2)-6.44%
Min Revenue beat(2)-6.58%
Max Revenue beat(2)-6.31%
Revenue beat(4)1
Avg Revenue beat(4)-1.39%
Min Revenue beat(4)-9.64%
Max Revenue beat(4)16.97%
Revenue beat(8)2
Avg Revenue beat(8)-2.26%
Revenue beat(12)6
Avg Revenue beat(12)3.66%
Revenue beat(16)7
Avg Revenue beat(16)3.33%
PT rev (1m)0%
PT rev (3m)-5.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.29%
EPS NY rev (1m)0%
EPS NY rev (3m)13.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-14.86%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.32%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.53 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.75 | ||
| P/tB | 10.79 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.25
EYN/A
EPS(NY)-0.26
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS0.84
BVpS1.7
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.04% | ||
| ROE | -13.82% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 35.29% | ||
| FCFM | N/A |
ROA(3y)-8.99%
ROA(5y)-5.4%
ROE(3y)-12.84%
ROE(5y)-7.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.21%
GM growth 5Y-3.46%
F-Score5
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 16.11% | ||
| Cap/Sales | 2.34% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.7 | ||
| Quick Ratio | 3.32 | ||
| Altman-Z | -0.49 |
F-Score5
WACC8.88%
ROIC/WACCN/A
Cap/Depr(3y)21.19%
Cap/Depr(5y)28.79%
Cap/Sales(3y)2.61%
Cap/Sales(5y)2.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.33%
EPS Next Y-57.34%
EPS Next 2Y-11.52%
EPS Next 3Y9.88%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.75%
Revenue growth 3Y-26.21%
Revenue growth 5Y-4.59%
Sales Q2Q%-12.62%
Revenue Next Year-12.67%
Revenue Next 2Y-7.9%
Revenue Next 3Y-2.65%
Revenue Next 5Y0.51%
EBIT growth 1Y30.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year26.37%
EBIT Next 3Y30.01%
EBIT Next 5Y23.26%
FCF growth 1Y-414.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-816.42%
OCF growth 3YN/A
OCF growth 5YN/A
OPKO HEALTH INC / OPK FAQ
Can you provide the ChartMill fundamental rating for OPKO HEALTH INC?
ChartMill assigns a fundamental rating of 2 / 10 to OPK.
What is the valuation status of OPKO HEALTH INC (OPK) stock?
ChartMill assigns a valuation rating of 0 / 10 to OPKO HEALTH INC (OPK). This can be considered as Overvalued.
What is the profitability of OPK stock?
OPKO HEALTH INC (OPK) has a profitability rating of 1 / 10.
What is the financial health of OPKO HEALTH INC (OPK) stock?
The financial health rating of OPKO HEALTH INC (OPK) is 5 / 10.
Can you provide the expected EPS growth for OPK stock?
The Earnings per Share (EPS) of OPKO HEALTH INC (OPK) is expected to decline by -57.34% in the next year.